Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and pathological characteristic of metastatic malignant mesothelioma initially diagnosed by lymph node biopsy.
Zhu XL, Gao LM, Li F, Liu WP, Zhang WY, Li GD, Zhang XH, Chen M, Liu XY, Zhao S. Zhu XL, et al. Pathol Res Pract. 2017 Jun;213(6):598-605. doi: 10.1016/j.prp.2017.05.003. Epub 2017 May 13. Pathol Res Pract. 2017. PMID: 28551387
BACKGROUND: It is a great challenge for pathologists to initially diagnose metastatic malignant mesothelioma (MM) by the lymph node biopsy without any history of primary MM. ...Correct diagnosis of MM metastasis by lymph node biopsy were based on detailed und …
BACKGROUND: It is a great challenge for pathologists to initially diagnose metastatic malignant mesothelioma (MM) by th …
Gender differences in molecular-guided therapy recommendations for metastatic malignant mesothelioma.
Taghizadeh H, Zöchbauer-Müller S, Mader RM, Müllauer L, Klikovits T, Bachleitner-Hofmann T, Hoda MA, Prager GW. Taghizadeh H, et al. Thorac Cancer. 2020 Jul;11(7):1979-1988. doi: 10.1111/1759-7714.13491. Epub 2020 May 21. Thorac Cancer. 2020. PMID: 32438515 Free PMC article. Clinical Trial.
Eventually, four patients received the targeted therapy, of whom one patient subsequently achieved stable disease. CONCLUSIONS: Our observations suggest that a molecular-guided treatment approach is feasible for the management of advanced malignant mesothelioma. ...
Eventually, four patients received the targeted therapy, of whom one patient subsequently achieved stable disease. CONCLUSIONS: Our obser